Brown Advisory Inc Ampio Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	BUY	$0.39 - $0.7 $6,513 - $11,690	16,700 New	16,700 $6,000
Q1 2018 May 14, 2018	SELL	$2.16 - $3.48 $36,072 - $58,116	-16,700 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	16,700	16,700 $9,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.